American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19

A Cuker, EK Tseng, R Nieuwlaat… - Blood …, 2021 - ashpublications.org
Background: Coronavirus disease 2019 (COVID-19)–related critical illness and acute illness
are associated with a risk of venous thromboembolism (VTE). Objective: These evidence …

American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19

A Cuker, EK Tseng, R Nieuwlaat… - Blood …, 2021 - einstein.elsevierpure.com
Background: Coronavirus disease 2019 (COVID-19)-related critical illness and acute illness
are associated with a risk of venous thromboembolism (VTE). Objective: These evidence …

[HTML][HTML] American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19

A Cuker, EK Tseng, R Nieuwlaat… - Blood …, 2021 - ncbi.nlm.nih.gov
Background: Coronavirus disease 2019 (COVID-19)–related critical illness and acute illness
are associated with a risk of venous thromboembolism (VTE). Objective: These evidence …

American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19.

A Cuker, EK Tseng, R Nieuwlaat, P Angchaisuksiri… - Blood …, 2021 - europepmc.org
Background Coronavirus disease 2019 (COVID-19)-related critical illness and acute illness
are associated with a risk of venous thromboembolism (VTE). Objective These evidence …

American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19

A Cuker, KM Sanfilippo - 2021 - digitalcommons.wustl.edu
Background: Coronavirus disease 2019 (COVID-19)–related critical illness and acute illness
are associated with a risk of venous thromboembolism (VTE). Objective: These evidence …

American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19

A Cuker, EK Tseng, R Nieuwlaat… - Blood …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Coronavirus disease 2019 (COVID-19)-related critical illness and acute illness
are associated with a risk of venous thromboembolism (VTE). Objective These evidence …

[HTML][HTML] American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19

A Cuker, EK Tseng, R Nieuwlaat, P Angchaisuksiri… - Blood Advances, 2021 - Elsevier
Background: Coronavirus disease 2019 (COVID-19)–related critical illness and acute illness
are associated with a risk of venous thromboembolism (VTE). Objective: These evidence …

American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19

A Cuker, EK Tseng, R Nieuwlaat, P Angchaisuksiri… - Blood Advances, 2021 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Background:</jats: title>< jats: p> Coronavirus disease 2019
(COVID-19)–related critical illness and acute illness are associated with a risk of venous …

American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19

A Cuker, EK Tseng, R Nieuwlaat… - Blood …, 2021 - profiles.wustl.edu
Background: Coronavirus disease 2019 (COVID-19)-related critical illness and acute illness
are associated with a risk of venous thromboembolism (VTE). Objective: These evidence …

American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19

A Cuker, EK Tseng, R Nieuwlaat… - Blood …, 2021 - scholarlypublications …
Background: Coronavirus disease 2019 (COVID-19)-related critical illness and acute illness
are associated with a risk of venous thromboembolism (VTE). Objective: These evidence …